Skip to main content
. 2022 Oct 31;109(3):178–185. doi: 10.1136/heartjnl-2022-321114

Figure 4.

Figure 4

Forest plot showing the HRs and 95% CIs for studies examining cardiovascular (A, B), major bleeding (C) and mortality (D) outcomes of non-vitamin K antagonist oral anticoagulant overdosing compared with recommended dosing. SE, systemic embolism; TIA, transient ischaemic attack.